Opt-Out Syphilis Screening in ED Improves Screening, Diagnosis
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 13, 2024 -- Implementation of opt-out emergency department syphilis screening leads to a dramatic increase in screening and diagnosis, especially among pregnant individuals, according to a study published online Sept. 10 in Open Forum Infectious Diseases.
Kimberly A. Stanford, M.D., from University of Chicago, and colleagues examined trends in syphilis screening and diagnosis before and after implementation of an opt-out emergency department syphilis screening intervention in May 2019.
The researchers found that syphilis screening increased from 3.6 to 24.4 percent of encounters. Presumed active syphilis infection (PAI) increased 288 percent during the study period, from 161 patients (3.1 percent of those screened) to 624 patients (1.7 percent of those screened). Similarly, the proportion of women with PAI increased from 25.6 to 42.5 percent, despite no change in the proportion of women screened. Following implementation, 23.6 percent of PAI were tested for a urogenital sexually transmitted infection (STI) in the emergency department and 9.0 percent presented with symptoms of an STI by diagnosis code. Screening increased from 5.9 to 49.9 percent of encounters among pregnant people, and syphilis diagnosis increased 750 percent (from two cases to 15).
“Opt-out screening will be an important strategy in the effort to address the syphilis epidemic,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.